Anti-human OX40L antibodies and methods of treating graft versus host disease with the same
US9434785B1 · kind B1 · utility
10Cited by
12References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2015 |
| Grant date | Sep 6, 2016 |
| Priority date | — |
| Expiry date | Nov 9, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/90
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.